Jeff Yass’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Jeff Yass’s Portfolio TLIS Stock Details TLIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,953	Closed	-$1.03M	–	14104
2021 Q3	$1.03M	Buy	+10,953	New	+$1.46M	﹤0.01%	7495

Other funds holding TLIS

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Jeff Yass's TLIS Position: Q3 2024 in Review

Jeff Yass sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q3 2024, closing a stake of 11,607 shares — an estimated $102K sold.

Jeff Yass first reported a position in TLIS in Q4 2021 and held it in 9 quarters. The position peaked at $153K in Q1 2024. 2 funds tracked by Wall St. Rank hold TLIS as of Q3 2024.

Jeff Yass reported no remaining Talis Biomedical Corporation Common Stock position as of Q3 2024 after selling out during the quarter.
Jeff Yass sold 11,607 Talis Biomedical Corporation Common Stock shares in Q3 2024, an estimated $102K.
Jeff Yass first reported a position in Talis Biomedical Corporation Common Stock in Q4 2021 and held it in 9 quarters.
Jeff Yass's Talis Biomedical Corporation Common Stock position peaked at $153K in Q1 2024.
2 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.